TickerGuard
Buy Day today: Neutral (57) Mixed market breadth · major macro event coming up
IFRX

InflaRx N.V.

Healthcare · Biotechnology

1.70$ -5.0% vs. previous close Closing price · As of: Oct 1, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow IFRX
Line item 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – – – – –
– -17.5% +115.2% +145.1% +281.1% +7.5% -6.1% -10.9% -4.8% -14.6% -16.9%
– +257.2% +424.2% +165.6% -43.5% -83.7% +287.9% +39.5% -43.5% +19.1% +9.3%
– +129.0% +249.1% -33.6% -4.3% -65.1% +66.9% – – – –
– +347.8% +113.6% -29.0% -227.7% – – -735.4% – -327.0% –
– +307.7% +181.1% +440.9% -26.2% -84.2% -59.9% +329.9% -50.1% -42.2% +137.1%
– +307.7% +215.1% +59,451.5% – +5.0% -221.5% – -191.4% – -94.1%
– – – – – – – – – – –
– -100.0% +282.3% -54.7% -100.0% – – – – – –
– – +0.0% +0.0% +0.0% +23.7% -1.5% +1.0% +2.6% +3.8% -7.9%
– -56.2% +252.6% -54.4% -100.6% – +571.4% -96.9% +2,634.8% -99.3% +8,181.0%
– – +264.8% -172.1% – – – -3,649.3% – – -103.2%
– – – – – – – – – – –

Data as of: October 1, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?